These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 26936013

  • 1. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
    Ma LG, Bian SB, Cui JX, Xi HQ, Zhang KC, Qin HZ, Zhu XM, Chen L.
    Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
    [Abstract] [Full Text] [Related]

  • 2. Chibby is a weak regulator of β-catenin activity in gastric epithelium.
    Li FQ, Chiriboga L, Black MA, Takemaru KI, Raffaniello RD.
    J Cell Physiol; 2019 Feb; 234(2):1871-1879. PubMed ID: 30063079
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
    Hu M, Zhao T, Liu J, Zou Z, Xu Q, Gong P, Guo H.
    Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
    [Abstract] [Full Text] [Related]

  • 4. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M, Han YM, Han Q, Rong XZ, Liu XF, Ln XY.
    J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
    [Abstract] [Full Text] [Related]

  • 5. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F, Zhao WY, Li RK, Yang XM, Li J, Ao JP, Jiang SH, Kong FZ, Tu L, Zhuang C, Qin WX, He P, Zhang WM, Cao H, Zhang ZG.
    Int J Clin Exp Pathol; 2014 Oct; 7(10):6447-61. PubMed ID: 25400723
    [Abstract] [Full Text] [Related]

  • 6. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z, Xie J, Cai Y, Yang S, Chen Y, Wu H.
    Diagn Pathol; 2015 Jul 28; 10():128. PubMed ID: 26215716
    [Abstract] [Full Text] [Related]

  • 7. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L, Lin L, Chen X, Sun L, Liao Y, Huang N, Liao W.
    Oncotarget; 2015 May 10; 6(13):11492-506. PubMed ID: 25895023
    [Abstract] [Full Text] [Related]

  • 8. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
    Zeng M, Li B, Yang L, Guan Q.
    Mol Med Rep; 2021 Feb 10; 23(2):. PubMed ID: 33313949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM, Kyler SL, Rennoll SA, Jin G, Yochum GS.
    J Biol Chem; 2012 Apr 06; 287(15):11730-9. PubMed ID: 22337891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
    Cui J, Xi H, Cai A, Bian S, Wei B, Chen L.
    Int J Mol Med; 2014 Jul 06; 34(1):197-204. PubMed ID: 24788044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. β-catenin-mediated YAP signaling promotes human glioma growth.
    Wang Y, Pan P, Wang Z, Zhang Y, Xie P, Geng D, Jiang Y, Yu R, Zhou X.
    J Exp Clin Cancer Res; 2017 Sep 29; 36(1):136. PubMed ID: 28962630
    [Abstract] [Full Text] [Related]

  • 15. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.
    Chen XY, Wang ZC, Li H, Cheng XX, Sun Y, Wang XW, Wu ML, Liu J.
    Hum Pathol; 2005 Dec 29; 36(12):1294-301. PubMed ID: 16311123
    [Abstract] [Full Text] [Related]

  • 16. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, Feng YY, Cui L, Li DS, Liu Y, Du X, Guo MZ, Xu LY, Li EM, Wang HY, Xie D.
    Gastroenterology; 2012 Apr 29; 142(4):812-823.e15. PubMed ID: 22240482
    [Abstract] [Full Text] [Related]

  • 17. Effect of inhibition to Yes-related proteins-mediated Wnt/β-catenin signaling pathway through miR-195-5p on apoptosis of gastric cancer cells.
    Zhao DL, Wu QL.
    Eur Rev Med Pharmacol Sci; 2019 Aug 29; 23(15):6486-6496. PubMed ID: 31378888
    [Abstract] [Full Text] [Related]

  • 18. VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer.
    Li H, Wang Z, Zhang W, Qian K, Liao G, Xu W, Zhang S.
    Med Oncol; 2015 Mar 29; 32(3):83. PubMed ID: 25701461
    [Abstract] [Full Text] [Related]

  • 19. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Ye J, Xu J, Li Y, Huang Q, Huang J, Wang J, Zhong W, Lin X, Chen W, Lin X.
    Mol Oncol; 2017 Sep 29; 11(9):1208-1224. PubMed ID: 28580735
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J, Kou YB, Zhu JS, Chen WX, Li S.
    Int J Oncol; 2014 Apr 29; 44(4):1268-76. PubMed ID: 24481712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.